MicroRNAs have been implicated in many critical cellular processes including apoptosis. We have previously found that apoptosis in pancreatic cancer cells was induced by adamantyl retinoid-related (ARR) molecule 3-Cl-AHPC. Here we report that 3-Cl-AHPC-dependent apoptosis involves regulating a number of microRNAs including miR-150* and miR-630. 
Introduction
Following their initial discovery in 1993, microRNAs have been studied for their purpose by a large number of authors [1] . The ability of microRNAs to regulate the expression of a wide variety of genes at the post-transcriptional level has been well documented [2] . These small RNA molecules are conserved and expressed in a large number of organisms including Homo sapiens and play important roles in the regulation of crucial biological processes including cell proliferation, differentiation and apoptosis.
MicroRNAs are transcribed in the nucleus primarily by RNA polymerase as long primary transcripts (pre-microRNAs). These molecules are then processed in the nucleus by RNAse III Drosha into 70-to 100-nucleotides pre-microRNAs and then exported into the cytoplasm where they are further processed by the RNAse III Dicer to generate double stranded RNAs (dsRNA) of approximately 22 nucleotides [3] . Whether, there is degradation of the antisense strand at this point is controversial. Recent evidence strongly suggests that the reverse mRNA strand may not be degraded and may play a significant role in the regulation of a number of cellular functions [4] . The remaining mature singlestranded micro RNA inhibits translation by joining a complex that binds complementary to the 39-UTR of the target gene. Through complimentary binding, specific microRNAs have been shown to target a number of genes enhancing or inhibiting their expression, resulting in pleiotropic effects on a number of cellular functions [5] .
Dysregulation of microRNA expression has been associated with cancer initiation and progression by regulating expression of tumor suppressors and oncogenes. It has been previously demonstrated that the microRNA profiles found in pancreatic carcinoma tissues differ significantly from those found in normal pancreatic tissue or in pancreatitis [6] . It has been hypothesized that enhanced or diminished expression of specific microRNAs may be powerful approach in the therapy of a number of malignancies [5] . A number of approaches to modulate micro-RNA expression have been devised. The adamantly-substituted retinoid related (ARR) molecules have been found to induce apoptosis in a variety of malignant cells both in vitro and in vivo [7] . A number of mechanisms have been proposed through which apoptosis is achieved by this class of molecules [7] .
We have previously demonstrated that ARRs are potent inducers of apoptosis in pancreatic cancer cells -a dismal disease with an often devastating prognosis [8] . We hypothesized that the exposure of cells to the 3-Cl-AHPC may result in the modulation of microRNA expression and that this differential microRNA expression may contribute to ARR-mediated inhibition of cellular proliferation and cell death induction. In the present series of experiments, we demonstrate that the ARRs indeed modulate microRNAs expression and that this enhancement of specific microRNA expression miR-150* and miR-630 results in the down regulation of IGF-1R protein which are important mediator of cellular growth and apoptosis induction.
Materials and Methods

Reagents and Cells
(E)-4-[3-(1-adamantyl)-4-hydroxyphenyl]-3-chlorocinnamic acid (3-Cl-AHPC) was synthesized as previously described [9] . Human pancreatic carcinoma cell lines, PANC-1 and MiaPaCa-2 were obtained from the American Type Culture Collection (ATCC, Rockville, MD) and maintained in DMEM-F12 medium containing 10% FBS and 100 mg/ml gentamycin. DMEM-F12 medium, fetal bovine serum (FBS) and lipofectamine 2000 were purchased from Invitrogen (Carlsbad, CA). Antibodies and their sources were as follows: antibodies for flow cytometry, CD44-PE, CD24-FITC from BD Biosciences (San Jose, CA); anti-IGF-1Rb, anti-SMAD1, anti-cleaved caspase 3 (Asp-175), anti-caspase 3 were from Cell Signaling Technology (Boston, MA); anti-EGFR, anti-CDK6, anti-c-Myb and anti-Bcl2 antibodies (Santa Cruz Biotechnology, Santa Cruz, CA); Cdc14A and ABCC1 from Abcam, Cambridge, MA and Thermo Scientific, Rockford, IL, respectively; and anti-a-tubulin and b-actin antibody (Oncogene Research Products, Boston, MA). Puromycin was purchased from Sigma-Aldrich (St. Louise, MO).
miRNA microarray analysis and validation
PANC-1 cells were exposed to 1 mM 3-Cl-AHPC for 30 h. Total RNA from 3-Cl-AHPC treated and untreated cells was extracted with TRIzol reagent (Invitrogen, Carlsbad, CA) and then sample preparation, hybridization to G4470A 15K Human miRNA Microarray (V2) (Agilent Technologies) and analysis were performed by Asuragen, Inc. (Austin, TX). For miRNA validation, total RNA was purified with RNeasy Mini kit (Qiagen) and 100 ng of RNA was used to prepare cDNA using TaqMan microRNA reverse transcription kit (Applied Biosystems) using specific microRNA primers. The miRNA sequence specific primer and probe of miR-134, miR-150*, miR-630, miR-345, miR-382, miR410, and miR129-5P, endogenous control RNU6B and TaqMan 26 PCR Master mix for TaqMan microRNA assays were purchased from Applied Biosystems and followed the protocol as described by manufacturer's instruction. Real-time qRT-PCR and analysis was performed in Applied Biosystems 7500 Real Time PCR system. Data analysis was performed with DCt values of miRNAs from each sample were calculated by normalizing with internal control RNU6B and each value were mean of three replicates.
mRNA Quantitation
Total RNA was prepared from PANC-1 cell lines using TRIzol as recommended by the manufacturer and purified using the Rneasy Mini Kit (Qiagen). For real time PCR, cDNA was prepared with the SuperScript III First-Strand cDNA synthesis system for RT-PCR (Invitrogen) and analyzed in triplicate using the 26 SYBR Green PCR Master Mix (Applied Biosystems) and the ABI Prism 7500 sequence detection system. PCR consisted of 40 cycles of 95uC for 10 min and then 95uC for 15 Small hairpin (sh)-RNA Myb expression vector was constructed by directionally cloning 59-BamH I and 3 EcoR I overhang nucleotides in a pSIREN-RetroQ vector according to the manufacturer's instructions (Clontech, Mountain View, CA). The gene silencing target sequences were from the coding sequence of the PubMed Accession numbers NM_001130172 and sh-RNA sequences, 59-TGAAGAAGCTGGTGGAACA -39 (Myb-KD1) and 59-ACAGATGACTGGAAAGTTA -39 (Myb-KD2),59-CAGAAGAGGAAGACAGAAT-39 (Myb-KD3) were synthesized from Integrated DNA technology Inc. shRNA regions in the plasmid backbone were confirmed by sequencing. shRNAMyb knockdown plasmids were stably transfected into PANC-1 cells using lipofectamine 2000 and the stable cell lines were selected with puromycin. The sh-vector-containing scrambled sequences in pSIREN-RetroQ vector was used as a control. For miR-630 overexpression, pEP-has-miR-630 expression vector was purchased from Cell Biolabs. Inc. (San Diego, CA). To inhibit miR-150* and miR-630 miRNAs, cells were transfected with antisense O'methylated miR-150* (OME-miR-150) and miR-630 (OME-miR-630) sequences; the sequences was synthesized from Integrated DNA Technology Inc. 
Apoptosis and Growth inhibition
Western blots
Cells were extracted with lysis buffer containing 25 mM Tris-Cl buffer (pH 8.0), 150 mM NaCl, 0.2% nonidet P-40, 10% glycerol 10 mM NaF, 8 mM b-glycerophosphate, 0.2 mM Na 3 VO 4 , 1 mM DTT, and 10 ml/ml protease inhibitor cocktail (Sigma Aldrich, St. Louise, MO) and Western blots were performed as we previously described [10] .
Chromatin Immunoprecipitation (ChIP) assay PANC-1 control cells were treated with 1 mM 3-Cl-AHPC for 24 h and the formaldehyde cross-linking and immunoprecipitation analysis was performed using a described method [10] . Chromatin lysate was incubated with 1 mg of anti-c-Myb antibody overnight at 4uC and immunoprecipitate complexes were collected with Dynal magntic beads (invitrogen). The following primers were used in in the ChIP assay samples for IGF-1R and Bcl2 promoter region, IGF-1R, forward, 59-AGGGGAATTTCATCCCAAAT-39; reverse, 59-AGGAAAAGTTCCCGCAGTG -39; Bcl2, forward, 59-CAGAGGAGGGCTTTCTTTCTTCTT-39; reverse, 59-CCCGGCCTCTTACTTCATTCT -39
Real-Time PCR was carried out as described previously in mRNA quantitation section. The data analysis was performed with DCt values from each c-Myb bound control. 3-Cl-AHPC treated samples were calculated by normalizing with input control and input treated value and each value was the mean of three replicates. The PCR products were run by electrophoresis on a 2% agarose gel and visualized by ethidium bromide staining and image captured by Gel Logic 2200 Imaging system, Molecular Imaging System Carestream Health, Inc.
Fluorescence-activated cell sorting (FACS) of CD44
+ / CD24 + cells and sphere formation
Cells were grown to 70-80% confluence, trypsinised and washed with sorting buffer (16PBS, 5% FCS). The cells were resuspended with 100 ml sorting buffer and incubated with 15-20 ml anti-CD44-PE and anti-CD24-FITC primary antibodies for 30 min at ice. The cells were washed and resuspended in 500 ml of sorting buffer and sorted using flow cytometry FACSAria system (BD Immunocytochemistry Systems, Franklin lakes, NJ).
Sorted CD44 + /CD24 + cells were suspended in serum-free stem cell medium containing DMEM/F12 (1:1) supplemented with B27 (Life Technologies, Gaithersburg, MD), 20 ng/ml EGF (Biomol International, Plymouth, PA), 20 ng/ml fibroblast growth factor (Biomol International, Plymouth, PA), and 100 mg/ml gentamycin. Approximately 150-200 cells per well were seeded in an ultra low-attachment 96-well plate (Corning Inc, Lowell, MA). 3-Cl-AHPC (1.0 mM) was added the day after cells were plated or after 7 days of sphere formation. Spheres were photographed and measured utilizing an Olympus microscope (OLYMPUS CKX41) and Olympus microscope digital camera with DP2-BSW software (Olympus soft imaging solutions GmbH, Germany). All statistics were performed using VassarStats web statistical software (Richard Lowry, Poughkeepsie, NY, USA). One-way analysis of variance (ANOVA) was performed to detect any differences between groups of sphere control, 3-Cl AHPC treated spheres. If the result of the ANOVA was significant (**P,0.01 vs control), pair wise comparisons between the groups were made by a post-hoc test (Tukey's HSD procedure). The significance level was set at **P,0.01 vs control and *P,0.05 vs control. Square brackets were used in the figures to indicate treatments that are significantly different from the control.
Results
3-Cl-AHPC mediated modulation of specific microRNAs
PANC-1 cell exposure to 1 mM 3-Cl-AHPC modulated expression of a number of microRNAs (Table 1 microarray  analysis) . Up-regulation of miR-134, miR-150*, miR-630, miR-345, miR-382, miR-410 and miR-129-5p and down-regulation of miR-202 and miR-578 were also observed (not shown). Further evidence of 3-Cl-AHPC-mediated miRNA modulation was obtained by real-time-PCR using a Taqman probe. Real-time Table 1 . 3-Cl-AHPC mediated modulation of microRNAs and target genes in PANC-1 cells. PCR demonstrated a statistically significant increase in the expression of the various microRNA species at 24 h ( Figure 1 ) in PANC-1 and MiaPaCa-2 cells. We also determined whether 3-Cl-AHPC modulation of microRNA expression resulted in up-or down-regulation of the genes targeted by these microRNAs; target genes were identified using the TargeScanHuman 5.0 data base. Modulation of the targeted genes including EGFR, c-Myb, CDC14A, IGF-1R, SMAD1, ABCC1, CPEB3, and CDK6 at both the mRNA (Figure 2A and B) and the protein level ( Figure 2C and E) was demonstrated within 24 h of 3-Cl-AHPC exposure. We also found that exposure of the PANC-1 cells to 3-Cl-AHPC for 24 h or 48 h increased expression of miR-150* while decreasing expression of c-Myb protein and IGF-1R in cells ( Figure 2D and E).
Over-expression of miR150* enhanced apoptosis by regulating c-Myb and IGF-1R and inhibited CD44 + /CD24 + stem cell-like spheres formation
Previous research has shown that miR-150 targets protooncogene transcription factor c-Myb during multiple steps of lymphocyte development [11] . In order to further demonstrate miR-150* modulation of c-Myb and IGF-1R in the PANC-1 cells, pre-miR-150* was stably over-expressed using a pre-miR-150* expression vector (pre-miR-150*) in PANC-1 cells resulting in a 7-fold increase in pre-miR-150* expression ( Figure 3A) ; pre-miR-150* over-expression resulted in a 80% inhibition of IGF-1R and c-Myb mRNA levels, a 50% decreased expression of c-Myb protein levels and a 32% decrease in IGF-1R expression ( Figure 3B-D) . In addition, both increased expression of premiR-150* by itself and in the presence of 3-Cl-AHPC significantly enhanced apoptosis in the PANC-1 cells ( Figure 3E ). Pre-miR- Figure 3E, lower right panel) . These results together implicate a pro-apoptotic role of miR-150 through its regulation of its target genes. Incubation of the PANC-1 cells with the inhibitor 29-O-meyhylated miR-150* antisense (OMEmiR150*) blocked 3-Cl-AHPC-mediated elevation of miR-150* levels and decreased in c-Myb expression strongly. This result suggests that 3-Cl-AHPC exerts its effects on c-Myb and IGF-1R expression through modulation of microRNAs ( Figure 4A-C) .
We hypothesized that c-Myb was anti-apoptotic in the PANC-1 cells and knockdown of c-Myb would enhance apoptosis of the cells both in the absence and the presence of 3-Cl-AHPC. Three clones of sh-Myb knockdown were generated in PANC-1 cells and low levels of c-Myb expression were found ( Figure 4D ). Knockdown of Myb demonstrated enhanced apoptosis in sh-Myb-KD cells. The addition of 3-Cl-AHPC to these cells also resulted in significantly greater levels of apoptosis than noted with cells transfected with only the vector ( Figure 4E ). Bcl-2 also plays a major role in antagonizing apoptosis by a number of agents [12] . It has been previously reported that c-Myb has a binding site in the Bcl-2 promoter and is a positive regulator of Bcl-2 expression. Decreased c-Myb levels in the inducible dominant-negative Myb protein FDCP-mix clone A4 cells resulted in decreased Bcl-2 expression [13] . We therefore examined Bcl-2 expression in cells exposed to 3-Cl-AHPC. We found significantly decreased Bcl-2 mRNA and protein expression in both PANC-1 and MiaPaCa-2 cells (Figure 5A and B). In addition, over expression of the pre-miR-150* resulted in decreased Bcl-2 protein expression suggesting it's regulated by miR-150* through c-Myb ( Figure 5C ). Chromatin immunoprecipitation assays were preformed to elucidate the mechanism by which 3-Cl-AHPC decreases Bcl-2 and IGF-1R expression. 3-Cl-AHPC exposure resulted in a significant decrease in the binding of c-Myb to the IGF-1R and Bcl-2 promoters ( Figure 5D ).
We have previously found that PANC-1 cells enriched for CD24/CD44 positivity possessed the stem cell-like feature of forming spheres in non-adherent growth conditions [8] . The addition of 3-Cl-AHPC to these spheres inhibited their growth and resulted in the induction of apoptosis. We therefore assessed the effect of elevated levels of pre-miR-150* and knockdown of c-Myb expression on the growth of these spheres ( Figures 6A, B and C) . Both elevated levels of pre-miR-150* and knockdown of c-Myb expression resulted in a significant growth inhibition of spheres at 7 and 14 days. Similarly, Zhang et al. [14] have recently shown that increased miR-150 expression inhibits CD133 positive liver cancer stem cells through its inhibition of c-Myb expression.
Target protein IGF-1R is regulated by miR-630
Galluzzi et al. have shown that miR-630 regulates cisplatin induced growth arrest by modulating cell cycle inhibitor p27 Kip1 and induces apoptosis in non-small cell lung cancer [14] . We have found that PANC-1 cells exposed to 3-Cl-AHPC enhanced miR-630 expression 6-fold. Using TargetScanHuman 5.1 software (Table 1) , we found potential miR-630 target genes IGF-1R and Cdc14A. miR-630 pairs to a 7 nucleotide conserved region located in position 2658-2665 of IGF-1R 39-UTR ( Figure 6D ). Overexpression of pre-miR-630 reduced IGF-1R mRNA and protein expression in transiently transfected cells (Figure 7A-D) whereas there was no change in the mRNA level target gene Cdc14A. 3-Cl-AHPC decreased the Cdc14A mRNA and protein expression (Figure 2A and C) . The mechanism by which 3-Cl-AHPC triggered decreased Cdc14A expression remains to be determined. The antisense inhibitor 29-O-methylated miR-630 blocked premiR-630 mediated IGF-1R mRNA degradation indicated that a miR-630 target gene is IGF-1R ( Figure 7E ). In addition, overexpression of pre-miR-630 enhanced inhibition and apoptosis significantly in PANC-1 cell (Figures 7F and G) . These results demonstrate the important role of miR-630 in the induction of apoptosis in pancreatic cancer cells.
Discussion
The importance of microRNA expression in maintaining normal cellular physiology has been well documented [15] . Inhibition of microRNA processing has been shown to enhance cellular transformation [16] . The incomplete knockdown of Dicer 1 in mouse lung adenocarcinoma cells resulted in increased cellular proliferation and invasiveness as well as enhanced in vivo tumor formation [16] . Furthermore, decreased microRNA expression in mouse embryonic fibroblasts resulted in incomplete transformation of the cells [16] . The mechanisms by which microRNA expression decreases in the malignant cells as opposed to the normal cells is not clear. Recently, epigenetic regulation of microRNA expression has been demonstrated in a variety of tumors [17] . MicroRNA genes were silenced in human tumors by aberrant hypermethylation of CpG islands adjacent to and surrounding the microRNA genes and by acetylation of the microRNA gene associated histones [17] . It has been found that a higher proportion of known microRNA genes have been found to be epigenetically regulated through methylation (11.6%) than that found in the protein-encoding genes (1-2%) [18, 19] .
In the present publication, we have demonstrated that 3-Cl-AHPC modulates expression of a number of microRNAs that regulate the translation and degradation of mRNA. These mRNA encode the expression of proteins previously demonstrated to have important physiological roles in cellular proliferation and death. We have found that 3-Cl-AHPC exposure resulted in the upregulation of a number of microRNAs including miR-150* and miR-630. The significance of modulating of these microRNAs was demonstrated by observing subsequent modulation of their predicted target genes-including EGFR, c-Myb, SMAD1, ABCC1, CPEB3, IGF-1R and CDK6.
3-Cl-AHPC up-regulation of miR-150* resulted in the decreased expression of c-Myb and IGF-1R. Both proteins play critical roles in enhancing cellular proliferation. Over-expression of IGF-1R has been found in a variety of malignancies including pancreatic cancer [20] . Inhibition of IGF-1R utilizing small molecule kinase inhibitors has resulted in reduced pancreatic cancer growth [21] . We have previously shown that knock down of IGF-1R expression reduced pancreatic cancer cell proliferation while also enhancing 3-Cl-AHPC-mediated apoptosis [8, 22] . We have recently demonstrated that the expression of the microRNA miR-223 also suppresses cell proliferation by targeting IGF-1R. Enhanced miR-223 resulted in a decrease in IGF-1R expression as 3-Cl-AHPC-mediated 7-fold increase in miR-150* decreased IGF-1R and c-Myb expression. In order to further demonstrate miR-150* modulation of c-Myb and IGF-1R in the PANC-1 cells, we expressed pre-miR-150* in the cells and this resulted in a marked inhibition of IGF-1R and c-Myb mRNA and protein levels ( Figure 3) . Futhermore, addition of the miRNA inhibitor OME-150 with 3-Cl-AHPC blocked 3-CL-AHPC increase in miR-150* levels and 3-Cl-AHPC mediated decrease in c-Myb protein. These results strongly suggest that the 3-Cl-AHPCmediated decrease c-Myb levels was due to the 3-Cl-AHPC increase in pre-miR-150* expression. Moreover, enhanced expression of miR-150* in the PANC1 cells resulted in enhanced apoptosis in the cells both in the presence and absence of 3-Cl-AHPC. Thus enhanced mir-150* expression and its downregulation of c-Myb and IGF-1R have a significant effect on cell survival. Bcl-2 has been found to function as a negative regulator of apoptosis and has been found to play an important role in tumor cell survival [12, 23] . Bcl-2 down-regulation has been shown to be important in the induction of tumor cell death [12, 23] . We found that 3-Cl-AHPC exposure resulted in down-regulation of Bcl-2 expression by decreasing c-Myb expression and binding to the Bcl-2 promoter.
Aberrant expression of miR-150 has been reported in a number of malignant cells [24] [25] [26] [27] [28] . miR-150 was found to be downregulated in lymphoma and leukemia while its expression has been found to be increased in gastric and colorectal carcinomas. miR-150 appears, however, to have pleiotropic effects on malignant cells. Enhanced miR-150 expression promotes gastric carcinoma cell proliferation while it functions as a tumor suppressor in malignant lymphoma [26, 28] . Recently, it has been found that miR-150 directly targets the Muc4 39mRNA 39-UTR [22] . Binding of miR-150 to this region resulted in a marked decrease expression of MUC4 mRNA and protein. This decreased expression was shown to have a marked inhibitory effect on the pancreatic cell growth, migration, invasion and clonogenicity [24] .
EGFR plays an important role in pancreatic cancer cellular proliferation, metastatic spread, and apoptosis [29] . Elevated expression of EGFR has been found to be an independent poor prognostic factor in patients with pancreatic cancer [30] . EGFR is targeted by miR-133, decreasing expression of EGFR mRNA and protein in NSCLC cells [31] . We have found that exposure of the pancreatic cancer cells to 3-Cl-AHPC resulted in 4-fold increase in miR-134 levels with an associated marked inhibition of EGFR mRNA and protein levels. Previous research has shown that cisplatin (CDDP) induced a 5-fold increased expression of miR-630 at 12 h [14] . pre-miR-630 arrested cell growth at G0-G1 in lung cancer NSCLC A549 cells. We have found that 3-Cl-AHPC up-regulates of miR-630 expression. pre-miR-630 reduced target protein IGF-1R levels and induced growth inhibition and apoptosis in PANC-1 cells. These results suggested that IGF-1R is the target gene of miR-630. Modulation of miRNA levels by a number of agents has been demonstrated to function as cancer chemopreventive agents [32] . Epigallocatechin gallate an important cancer chemopreventative agent of green tea has been shown to upregulate miR-16 with subsequent down-regulation of Bcl-2 in hepatocarcinoma cells [33] . Sun et al. have recently shown that the antitumor agent curcumin which has been shown to inhibit the proliferation and induce apoptosis of a variety of tumor types may mediate the death of pancreatic cancer cells through its upregulation of the expression of miR-22 and the subsequent targeting of the transcription factor SP1 and estrogen receptor 1 [34] . Similarly, the anti-tumor effects of the natural antioxidant revesterol and the isoflavone genistein have been partially or wholly attributed to their ability the levels of a variety of miR levels [33, 35] . More direct approaches have been utilized to modulate miRNA levels both in vitro and in vivo [36] . These approaches have included the use of anti miRNA oligonucleotides (AMO) miRNA spongesthat have multiple miRNA binding sites thus possessing the capacity to sequester multiple miRNA -and miRNA masks -that are complementary to the 39-untranslated region of the target miRNA and result in the competitive inhibition of miRNA modulation of its target genes [36, 37] A number of microRNA delivery systems have been developed and have shown promise both in vitro and in vivo in their ability to enhance specific miRNA expression in the malignant cells resulting in the inhibition of tumor growth [38, 39] .
In this report we show that 3-Cl-AHPC modulated exposure to PANC-1 cells modulate miRNAs that appear to play key roles in growth inhibition and apoptosis induction in pancreatic cancer cells. Specifically, we've shown that up-regulation of miR-150* and miR-630 is important to the inhibition of IGF-1R, which inhibits growth and induces apoptosis in pancreatic cancer cells. This study broadly supports the framework that microRNAs are essential for apoptosis induction and growth inhibition in pancreatic cancer. Further understanding microRNAs regulation may have promising clinical implications for the treatment of cancer. 
